e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Novel and old entities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Identifying Inflammatory Myopathies to optimise Interstitial lung disease treatment strategies>
A. O'Mahony (Co. Cork, Ireland)
Source:
International Congress 2017 – Novel and old entities
Session:
Novel and old entities
Session type:
Thematic Poster
Number:
3839
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. O'Mahony (Co. Cork, Ireland). Identifying Inflammatory Myopathies to optimise Interstitial lung disease treatment strategies>. 3839
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy
Source: International Congress 2014 – ILDs 4
Year: 2014
Aetiological panorama in the diagnosis of interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014
Childhood diffuse parenchymal lung diseases: Diagnosis, treatment and outcome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
LATE-BREAKING ABSTRACT: Current management of patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014
Statin-induced lung diseases
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Markers of injury and fibrosis in occupational interstitial lung diseases (OILD)
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015
Factors predicting resolution in nitrofurantoin-induced lung disease
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Antisynthetase syndrome related interstitial lung disease may have a better treatment response than other forms of Idiopathic Inflammatory Myopathies: a multi-national study
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease?
Source: International Congress 2014 – ILDs 5
Year: 2014
Childhood interstitial lung disease: A diagnostic challenge
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Interstitial lung disease: improving classification and prognosis
Source: Virtual Congress 2021 – Clinical year in review
Year: 2021
Acute exacerbation of idiopathic pulmonary fibrosis: Analysis in a post-marketing surveillance of pirfenidone
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014
Biomarkers for interstitial lung disease
Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease
Year: 2016
Pregnancy course in patients with interstitial lung diseases
Source: International Congress 2014 – ILDs 5
Year: 2014
HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Pulmonary function changes during treatment with rituximab in patients with rheumatoid arthritis
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
Multidisciplinary board for interstitial lung disease: Relevance for real life?
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities
Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept